NORETHINDRONE AND ETHINYL ESTRADIOL

NORETHINDRONE AND ETHINYL ESTRADIOL was reported 1160 times

NORETHINDRONE AND ETHINYL ESTRADIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VOCAL CORD AUGMENTATION 2 0.2500
1 HCOV-NL63 INFECTION 1 0.1250
2 HOMANS' SIGN 1 0.0667
3 EXPOSURE KERATITIS 2 0.0667
4 OVARIAN CLEAR CELL CARCINOMA 2 0.0513
5 BRAIN STEM AUDITORY EVOKED RESPONSE ABNORMAL 2 0.0426
6 CERVICAL FRIABILITY 1 0.0333
7 EAR, NOSE AND THROAT EXAMINATION ABNORMAL 2 0.0333
8 CONTRACEPTIVE IMPLANT 1 0.0333
9 LAXATIVE ABUSE 1 0.0333
10 KERATOLYSIS EXFOLIATIVA ACQUIRED 1 0.0312
11 FEAR OF PREGNANCY 1 0.0303
12 MENINGIOMA SURGERY 2 0.0303
13 FOLLICULAR LYMPHOMA STAGE III 1 0.0250
14 FEMALE SEX HORMONE LEVEL ABNORMAL 1 0.0227
15 MESENTERIC VASCULAR OCCLUSION 1 0.0208
16 BLOOD CAFFEINE INCREASED 1 0.0179
17 OPTIC DISC DRUSEN 1 0.0159
18 HEPATOBILIARY SCAN ABNORMAL 2 0.0157
19 EYELID CONTUSION 1 0.0149
20 APPLICATION SITE ANAESTHESIA 1 0.0143
21 ACTINIC ELASTOSIS 1 0.0132
22 CLINICALLY ISOLATED SYNDROME 1 0.0105
23 PORTAL FIBROSIS 2 0.0093
24 UPPER MOTOR NEURONE LESION 2 0.0091
25 CONGENITAL MEGACOLON 1 0.0088
26 CHOLESTEROSIS 2 0.0078
27 BILOMA 1 0.0071
28 FIBROMUSCULAR DYSPLASIA 1 0.0061
29 ANAPLASTIC ASTROCYTOMA 1 0.0061
30 CARNITINE DEFICIENCY 1 0.0058
31 HEPATIC ADENOMA 3 0.0058
32 BLOOD COPPER INCREASED 1 0.0056
33 FEEDING TUBE USER 2 0.0055
34 GINGIVAL INFLAMMATION 1 0.0053
35 FAILED INDUCTION OF LABOUR 1 0.0052
36 CEREBRAL VENOUS THROMBOSIS 9 0.0050
37 GASTRODUODENITIS 1 0.0049
38 OESOPHAGEAL MASS 1 0.0048
39 INTRACRANIAL VENOUS SINUS THROMBOSIS 5 0.0047
40 CHLOASMA 2 0.0043
41 GENITAL DISORDER FEMALE 1 0.0041
42 DERMATITIS HERPETIFORMIS 1 0.0041
43 ELECTROCARDIOGRAM P WAVE ABNORMAL 1 0.0041
44 KERATOSIS PILARIS 1 0.0040
45 GLAUCOMA SURGERY 1 0.0039
46 HYPERHOMOCYSTEINAEMIA 1 0.0038
47 TRANSVERSE SINUS THROMBOSIS 2 0.0038
48 BLOOD CORTISOL INCREASED 1 0.0038
49 SUPERIOR SAGITTAL SINUS THROMBOSIS 3 0.0038
50 GALLBLADDER NON-FUNCTIONING 2 0.0035
51 ALOPECIA UNIVERSALIS 1 0.0034
52 CONGENITAL CHOROID PLEXUS CYST 1 0.0033
53 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 1 0.0032
54 FEAR OF EATING 1 0.0032
55 HEPATIC VEIN THROMBOSIS 1 0.0032
56 PARAKERATOSIS 1 0.0031
57 LIPOPROTEIN (A) INCREASED 1 0.0031
58 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
59 AMINO ACID LEVEL DECREASED 1 0.0030
60 COLONIC STENOSIS 1 0.0029
61 LARGE INTESTINAL ULCER HAEMORRHAGE 1 0.0029
62 LYMPHOID TISSUE HYPERPLASIA 1 0.0028
63 GLOBULINS INCREASED 1 0.0027
64 PREGNANCY ON ORAL CONTRACEPTIVE 7 0.0027
65 STRESS AT WORK 3 0.0027
66 MESENTERIC ARTERY THROMBOSIS 1 0.0026
67 MYCOPLASMA INFECTION 2 0.0026
68 DROPPED HEAD SYNDROME 1 0.0025
69 ARTERY DISSECTION 1 0.0024
70 CAROTID ARTERY DISSECTION 1 0.0023
71 CORONARY ARTERY DISSECTION 2 0.0023
72 FIBROADENOMA OF BREAST 1 0.0022
73 DIABETIC EYE DISEASE 1 0.0022
74 FACIAL ASYMMETRY 2 0.0021
75 HEMIANOPIA 2 0.0020
76 CEREBRAL ARTERY THROMBOSIS 1 0.0019
77 DYSPNOEA EXACERBATED 1 0.0019
78 AUTOSCOPY 1 0.0019
79 MORNING SICKNESS 1 0.0018
80 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
81 CHOLECYSTITIS CHRONIC 12 0.0018
82 BILIARY DYSKINESIA 3 0.0018
83 FLASHBACK 1 0.0017
84 JUGULAR VEIN THROMBOSIS 3 0.0017
85 COLON CANCER STAGE IV 1 0.0017
86 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
87 PERSISTENT FOETAL CIRCULATION 1 0.0016
88 UTERINE SPASM 3 0.0016
89 VESTIBULAR DISORDER 2 0.0016
90 NAIL PSORIASIS 1 0.0016
91 VULVOVAGINAL DRYNESS 5 0.0015
92 GALLBLADDER INJURY 3 0.0015
93 C-REACTIVE PROTEIN DECREASED 1 0.0015
94 GALLBLADDER PAIN 1 0.0015
95 ABSCESS NECK 1 0.0015
96 ENDOMETRIOSIS 7 0.0015
97 FEELING OF RELAXATION 1 0.0015
98 PREMENSTRUAL SYNDROME 2 0.0015
99 MENSTRUAL DISORDER 12 0.0014
100 INGROWN HAIR 1 0.0014
101 POLYMENORRHOEA 5 0.0014
102 CEREBRAL THROMBOSIS 4 0.0014
103 ALCOHOL INTOLERANCE 1 0.0014
104 TRACHEOSTOMY 2 0.0014
105 CERVICAL RADICULOPATHY 1 0.0014
106 MOUTH SWELLING 8 0.0014
107 DISSOCIATIVE DISORDER 1 0.0014
108 HEMIANOPIA HOMONYMOUS 1 0.0014
109 GENITAL ULCERATION 1 0.0013
110 GASTROSTOMY 2 0.0013
111 METRORRHAGIA 22 0.0013
112 GALLBLADDER POLYP 1 0.0013
113 BLOOD FIBRINOGEN INCREASED 1 0.0013
114 DEVICE DAMAGE 1 0.0013
115 ANTICONVULSANT DRUG LEVEL INCREASED 2 0.0012
116 PORTAL VEIN THROMBOSIS 4 0.0012
117 ENDOMETRIAL HYPERPLASIA 1 0.0012
118 COELIAC DISEASE 12 0.0012
119 ARTHROPOD STING 2 0.0012
120 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
121 PERIORBITAL PAIN 1 0.0012
122 EROSIVE OESOPHAGITIS 2 0.0012
123 CAROTID ARTERY THROMBOSIS 1 0.0012
124 MYCOTIC ALLERGY 1 0.0012
125 LIP PRURITUS 1 0.0012
126 PAPILLARY THYROID CANCER 2 0.0011
127 AXIAL SPONDYLOARTHRITIS 1 0.0011
128 INFUSION SITE DISCOLOURATION 1 0.0011
129 VOCAL CORD PARALYSIS 2 0.0011
130 INTERMENSTRUAL BLEEDING 6 0.0011
131 LIP DISORDER 2 0.0011
132 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
133 COARCTATION OF THE AORTA 1 0.0010
134 ARTERIAL THROMBOSIS 2 0.0010
135 BLOOD IRON ABNORMAL 1 0.0010
136 COLON ADENOMA 1 0.0010
137 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
138 CORONARY ARTERY THROMBOSIS 2 0.0010
139 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
140 BUTTERFLY RASH 1 0.0010
141 ARTHRODESIS 1 0.0010
142 DYSMENORRHOEA 13 0.0010
143 BREAST DISCOMFORT 1 0.0010
144 TALIPES 3 0.0010
145 OPTIC NEUROPATHY 2 0.0009
146 ALLERGY TO ANIMAL 1 0.0009
147 DEVICE INEFFECTIVE 1 0.0009
148 CEREBRAL ARTERY OCCLUSION 1 0.0009
149 GASTRIC CANCER STAGE IV 2 0.0009
150 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
151 CEREBELLAR SYNDROME 2 0.0009
152 DEAFNESS NEUROSENSORY 3 0.0009
153 BIPOLAR I DISORDER 2 0.0009
154 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
155 METABOLIC SURGERY 1 0.0009
156 CARBON DIOXIDE DECREASED 1 0.0009
157 APPLICATION SITE DISCHARGE 1 0.0009
158 ACUTE PRERENAL FAILURE 1 0.0009
159 LUMBAR RADICULOPATHY 1 0.0009
160 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
161 MACROCYTOSIS 1 0.0009
162 PULMONARY INFARCTION 2 0.0008
163 MACULOPATHY 3 0.0008
164 DYSPLASIA 1 0.0008
165 FACIAL BONES FRACTURE 3 0.0008
166 HORMONE LEVEL ABNORMAL 4 0.0008
167 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
168 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
169 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
170 LIP DISCOLOURATION 1 0.0008
171 BAND SENSATION 1 0.0008
172 BRONCHIAL SECRETION RETENTION 1 0.0008
173 APPLICATION SITE EROSION 1 0.0008
174 MENOPAUSE 2 0.0008
175 DACRYOSTENOSIS ACQUIRED 1 0.0008
176 EXPOSURE VIA FATHER 1 0.0008
177 PATENT DUCTUS ARTERIOSUS 3 0.0008
178 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
179 HYPOMENORRHOEA 2 0.0007
180 NASAL DISCHARGE DISCOLOURATION 1 0.0007
181 BILIARY TRACT DISORDER 1 0.0007
182 JOINT INSTABILITY 1 0.0007
183 MAST CELL ACTIVATION SYNDROME 1 0.0007
184 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
185 CATAPLEXY 1 0.0007
186 GLUTEN SENSITIVITY 1 0.0007
187 UTERINE HAEMORRHAGE 3 0.0007
188 HEART VALVE INCOMPETENCE 2 0.0007
189 NAIL INFECTION 1 0.0007
190 PELVIC VENOUS THROMBOSIS 1 0.0007
191 RETINAL VEIN OCCLUSION 2 0.0007
192 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
193 FAT TISSUE INCREASED 1 0.0007
194 ABORTION 2 0.0007
195 STRABISMUS 2 0.0007
196 PHYSICAL DISABILITY 3 0.0007
197 PELVIC INFLAMMATORY DISEASE 1 0.0007
198 ATYPICAL PNEUMONIA 2 0.0007
199 GASTROINTESTINAL WALL THICKENING 1 0.0007
200 HYPOAESTHESIA FACIAL 1 0.0007
201 EPICONDYLITIS 1 0.0007
202 GINGIVAL HYPERTROPHY 1 0.0007
203 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
204 PHARYNGEAL PARAESTHESIA 1 0.0006
205 INTESTINAL ULCER 1 0.0006
206 BILE DUCT STONE 2 0.0006
207 OPTIC ATROPHY 1 0.0006
208 PRODUCT FORMULATION ISSUE 4 0.0006
209 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
210 IGA NEPHROPATHY 1 0.0006
211 THERAPEUTIC AGENT TOXICITY 2 0.0006
212 DEAFNESS BILATERAL 1 0.0006
213 FEMALE GENITAL TRACT FISTULA 1 0.0006
214 HEPATIC FIBROSIS 2 0.0006
215 BLOOD CHLORIDE INCREASED 1 0.0006
216 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
217 BREAST DISCHARGE 1 0.0006
218 INFUSION SITE DISCHARGE 1 0.0006
219 MITRAL VALVE DISEASE 1 0.0006
220 FEAR OF DISEASE 1 0.0006
221 MENORRHAGIA 11 0.0006
222 APPLICATION SITE DISCOMFORT 1 0.0006
223 OBSESSIVE THOUGHTS 1 0.0006
224 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
225 HYPERSEXUALITY 1 0.0005
226 ESSENTIAL HYPERTENSION 1 0.0005
227 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
228 SEBORRHOEA 2 0.0005
229 DIFFUSE ALOPECIA 1 0.0005
230 AUTOIMMUNE THYROIDITIS 2 0.0005
231 MENOMETRORRHAGIA 1 0.0005
232 CLEFT PALATE 1 0.0005
233 INFLAMMATORY BOWEL DISEASE 5 0.0005
234 VENOUS THROMBOSIS 2 0.0005
235 JOINT NOISE 1 0.0005
236 DECREASED INTEREST 3 0.0005
237 JOINT CREPITATION 1 0.0005
238 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
239 ENURESIS 2 0.0005
240 LIBIDO INCREASED 1 0.0005
241 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
242 VAGINAL HAEMORRHAGE 21 0.0005
243 CHEST INJURY 1 0.0005
244 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
245 PRE-EXISTING CONDITION IMPROVED 3 0.0005
246 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
247 PURULENT DISCHARGE 2 0.0005
248 PRODUCT DISPENSING ISSUE 2 0.0005
249 MEDICAL DEVICE PAIN 1 0.0005
250 ABNORMAL SENSATION IN EYE 2 0.0005
251 HYPERPROLACTINAEMIA 3 0.0005
252 PERIODONTITIS 1 0.0005
253 CHAPPED LIPS 2 0.0005
254 BACK INJURY 5 0.0005
255 OLIGOMENORRHOEA 1 0.0005
256 CERVICAL DYSPLASIA 1 0.0005
257 DANDRUFF 1 0.0005
258 INFECTIOUS MONONUCLEOSIS 1 0.0004
259 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
260 METASTASES TO LYMPH NODES 3 0.0004
261 LIP DRY 4 0.0004
262 DYSPAREUNIA 2 0.0004
263 HAEMANGIOMA 1 0.0004
264 METHAEMOGLOBINAEMIA 1 0.0004
265 ORAL SURGERY 1 0.0004
266 CHOLECYSTITIS 5 0.0004
267 MEDICATION RESIDUE PRESENT 2 0.0004
268 GASTROINTESTINAL OBSTRUCTION 1 0.0004
269 VISUAL FIELD DEFECT 3 0.0004
270 MENSTRUATION IRREGULAR 11 0.0004
271 UTERINE LEIOMYOMA 3 0.0004
272 PHARYNGEAL SWELLING 4 0.0004
273 INFLAMMATORY MARKER INCREASED 2 0.0004
274 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
275 OVARIAN CYST 4 0.0004
276 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
277 ENDODONTIC PROCEDURE 1 0.0004
278 EXCORIATION 1 0.0004
279 HOSTILITY 1 0.0004
280 PETIT MAL EPILEPSY 2 0.0004
281 PHLEBITIS 2 0.0004
282 PULMONARY EMBOLISM 37 0.0004
283 FOOD ALLERGY 3 0.0004
284 BLOOD CHLORIDE DECREASED 1 0.0004
285 CONGENITAL ANOMALY 3 0.0004
286 ACTINIC KERATOSIS 1 0.0004
287 NYSTAGMUS 2 0.0004
288 ANAL FISSURE 2 0.0004
289 GASTROINTESTINAL INJURY 1 0.0004
290 CHEILITIS 2 0.0004
291 MENSTRUATION DELAYED 4 0.0004
292 LARGE INTESTINAL ULCER 1 0.0004
293 BIPOLAR DISORDER 4 0.0004
294 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
295 LIP BLISTER 1 0.0004
296 CLUMSINESS 1 0.0004
297 BLOOD PHOSPHORUS INCREASED 1 0.0004
298 CHOLECYSTITIS INFECTIVE 1 0.0004
299 ATRIAL SEPTAL DEFECT 3 0.0004
300 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
301 UTERINE PERFORATION 3 0.0004
302 FACIAL PARALYSIS 3 0.0004
303 VENTRICULAR SEPTAL DEFECT 2 0.0003
304 LIP PAIN 1 0.0003
305 PSYCHOLOGICAL TRAUMA 3 0.0003
306 PRODUCT SUBSTITUTION ISSUE 20 0.0003
307 PYELONEPHRITIS 3 0.0003
308 EYELID MARGIN CRUSTING 1 0.0003
309 COMA SCALE ABNORMAL 1 0.0003
310 HAEMOTHORAX 1 0.0003
311 BILIARY COLIC 1 0.0003
312 LUMBAR SPINAL STENOSIS 1 0.0003
313 DEEP VEIN THROMBOSIS 22 0.0003
314 GALLBLADDER DISORDER 6 0.0003
315 CREPITATIONS 1 0.0003
316 TYPE 1 DIABETES MELLITUS 2 0.0003
317 ACNE CYSTIC 1 0.0003
318 LOSS OF EMPLOYMENT 1 0.0003
319 MEDICAL DEVICE DISCOMFORT 1 0.0003
320 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
321 INTRACARDIAC THROMBUS 1 0.0003
322 SWOLLEN TONGUE 10 0.0003
323 NASAL DRYNESS 2 0.0003
324 INFUSION SITE PRURITUS 1 0.0003
325 ABDOMINAL ADHESIONS 1 0.0003
326 FAECAL CALPROTECTIN INCREASED 1 0.0003
327 ENTERITIS 2 0.0003
328 LOOSE TOOTH 1 0.0003
329 CARDIAC FLUTTER 2 0.0003
330 CHOLELITHIASIS 10 0.0003
331 SOMNAMBULISM 2 0.0003
332 LISTLESS 1 0.0003
333 BLADDER DISORDER 3 0.0003
334 EXPOSURE DURING BREAST FEEDING 1 0.0003
335 PREGNANCY 6 0.0003
336 ANXIETY DISORDER 1 0.0003
337 POST-TRAUMATIC STRESS DISORDER 2 0.0003
338 BREAST MASS 2 0.0003
339 PRODUCT LABEL ISSUE 2 0.0003
340 EYE MOVEMENT DISORDER 2 0.0003
341 CROHN'S DISEASE 2 0.0003
342 DEPRESSION SUICIDAL 1 0.0003
343 HUNGER 4 0.0003
344 CARPAL TUNNEL SYNDROME 4 0.0003
345 DEFAECATION URGENCY 2 0.0003
346 EAR PRURITUS 1 0.0003
347 AMENORRHOEA 5 0.0003
348 HANGOVER 1 0.0003
349 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
350 EATING DISORDER 6 0.0003
351 BREAST PAIN 3 0.0003
352 IMPAIRED WORK ABILITY 6 0.0003
353 MAJOR DEPRESSION 2 0.0003
354 DENTAL CARIES 3 0.0003
355 AMYLASE INCREASED 1 0.0003
356 ARTHROPOD BITE 2 0.0003
357 MALNUTRITION 3 0.0003
358 IMPULSIVE BEHAVIOUR 1 0.0003
359 BREAST TENDERNESS 2 0.0003
360 CHOLECYSTECTOMY 3 0.0003
361 PARANASAL SINUS HYPERSECRETION 1 0.0003
362 MIGRAINE 25 0.0003
363 GINGIVAL DISORDER 1 0.0003
364 EMOTIONAL DISORDER 8 0.0003
365 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
366 EXPOSURE DURING PREGNANCY 16 0.0003
367 GASTROINTESTINAL INFLAMMATION 2 0.0003
368 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
369 NAIL DISCOLOURATION 1 0.0003
370 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
371 PROCEDURAL PAIN 7 0.0003
372 MOOD SWINGS 8 0.0003
373 OBSTRUCTION 1 0.0003
374 CANDIDIASIS 1 0.0002
375 FRUSTRATION TOLERANCE DECREASED 2 0.0002
376 FEELING HOT 15 0.0002
377 MUSCLE SPASTICITY 3 0.0002
378 ABNORMAL FAECES 2 0.0002
379 SPINAL OPERATION 3 0.0002
380 HYPERAESTHESIA 2 0.0002
381 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
382 CYST 3 0.0002
383 ACUTE CORONARY SYNDROME 2 0.0002
384 HEMIPLEGIA 2 0.0002
385 ABDOMINAL PAIN LOWER 6 0.0002
386 LUNG NEOPLASM 1 0.0002
387 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
388 SCAR 4 0.0002
389 HEPATIC LESION 1 0.0002
390 DELIRIUM 8 0.0002
391 PRODUCT DISPENSING ERROR 5 0.0002
392 ONYCHOMYCOSIS 1 0.0002
393 GROIN PAIN 2 0.0002
394 GRIP STRENGTH DECREASED 2 0.0002
395 FACIAL PAIN 2 0.0002
396 BRAIN NEOPLASM MALIGNANT 1 0.0002
397 LOSS OF LIBIDO 2 0.0002
398 HEAVY MENSTRUAL BLEEDING 2 0.0002
399 DRUG EFFECT DELAYED 1 0.0002
400 PELVIC PAIN 4 0.0002
401 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
402 PANIC ATTACK 8 0.0002
403 INJECTION SITE PAPULE 1 0.0002
404 ISCHAEMIA 1 0.0002
405 NIGHT SWEATS 7 0.0002
406 BLOOD GLUCOSE ABNORMAL 4 0.0002
407 FLUSHING 22 0.0002
408 NEPHROGENIC ANAEMIA 1 0.0002
409 PRODUCT DISTRIBUTION ISSUE 2 0.0002
410 PRODUCT DOSE OMISSION 14 0.0002
411 THERAPY CESSATION 11 0.0002
412 APPENDICITIS 2 0.0002
413 INJURY 15 0.0002
414 BLOOD PROLACTIN INCREASED 1 0.0002
415 SPINAL DISORDER 2 0.0002
416 PARALYSIS 3 0.0002
417 IMPAIRED QUALITY OF LIFE 3 0.0002
418 TYPE 2 DIABETES MELLITUS 7 0.0002
419 AFFECT LABILITY 2 0.0002
420 ANOSMIA 3 0.0002
421 HEPATOMEGALY 2 0.0002
422 THERAPY CHANGE 2 0.0002
423 ABDOMINAL TENDERNESS 1 0.0002
424 APPLICATION SITE SWELLING 1 0.0002
425 FLUID INTAKE REDUCED 1 0.0002
426 CORONARY ARTERY STENOSIS 1 0.0002
427 VAGINAL DISCHARGE 2 0.0002
428 DYSPHORIA 1 0.0002
429 HYPOTHERMIA 2 0.0002
430 DRUG DISPENSING ERROR 3 0.0002
431 MOTOR DYSFUNCTION 2 0.0002
432 INSURANCE ISSUE 3 0.0002
433 TINNITUS 9 0.0002
434 INITIAL INSOMNIA 2 0.0002
435 EAR DISCOMFORT 2 0.0002
436 CEREBRAL ISCHAEMIA 1 0.0002
437 PERIORBITAL OEDEMA 1 0.0002
438 MENINGIOMA 3 0.0002
439 MALABSORPTION 1 0.0002
440 UNINTENDED PREGNANCY 2 0.0002
441 WEIGHT FLUCTUATION 2 0.0002
442 PRODUCT ODOUR ABNORMAL 2 0.0002
443 PARTIAL SEIZURES 1 0.0002
444 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
445 THROMBOSIS 15 0.0002
446 BRUXISM 1 0.0002
447 THROAT TIGHTNESS 5 0.0002
448 PULMONARY THROMBOSIS 2 0.0002
449 INTESTINAL ISCHAEMIA 1 0.0002
450 HYPERKERATOSIS 1 0.0002
451 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
452 VENTRICULAR FIBRILLATION 2 0.0002
453 NERVE INJURY 2 0.0002
454 INTRACRANIAL PRESSURE INCREASED 1 0.0002
455 FISTULA 2 0.0002
456 CHOLECYSTITIS ACUTE 1 0.0002
457 GRANULOCYTOPENIA 1 0.0002
458 DERMATITIS CONTACT 2 0.0002
459 CARDIAC VALVE DISEASE 1 0.0002
460 ABORTION SPONTANEOUS 7 0.0002
461 PARANOIA 3 0.0002
462 HYPERVENTILATION 1 0.0002
463 NERVOUSNESS 9 0.0002
464 LOCAL SWELLING 3 0.0002
465 COLD SWEAT 3 0.0002
466 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
467 ENERGY INCREASED 1 0.0002
468 THIRST 3 0.0002
469 POLLAKIURIA 7 0.0002
470 HEARING IMPAIRED 1 0.0002
471 THYROID CANCER 2 0.0002
472 GASTROENTERITIS VIRAL 3 0.0002
473 RESTLESS LEGS SYNDROME 3 0.0002
474 FIBROMYALGIA 4 0.0002
475 CEREBRAL INFARCTION 4 0.0002
476 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
477 BALANCE DISORDER 14 0.0002
478 HEPATIC STEATOSIS 3 0.0002
479 BLEPHAROSPASM 1 0.0002
480 MULTIPLE INJURIES 1 0.0002
481 ACNE 12 0.0002
482 INJECTION SITE IRRITATION 2 0.0002
483 FOREIGN BODY SENSATION IN EYES 1 0.0002
484 GALACTORRHOEA 1 0.0002
485 EAR PAIN 3 0.0002
486 INJECTION SITE INDURATION 2 0.0002
487 DIPLOPIA 4 0.0002
488 ANGINA UNSTABLE 1 0.0002
489 HEPATITIS ACUTE 1 0.0002
490 SKIN FISSURES 3 0.0002
491 PLATELET COUNT INCREASED 2 0.0002
492 ABDOMINAL DISTENSION 16 0.0002
493 SEDATION 4 0.0002
494 INCORRECT PRODUCT STORAGE 2 0.0002
495 SINUS DISORDER 3 0.0002
496 SARS-COV-2 TEST POSITIVE 2 0.0002
497 ANXIETY 43 0.0002
498 EXPIRED PRODUCT ADMINISTERED 5 0.0002
499 INJECTION SITE BRUISING 12 0.0002
500 LIP SWELLING 5 0.0001
501 SKIN DISORDER 5 0.0001
502 IRRITABILITY 9 0.0001
503 INJECTION SITE PRURITUS 10 0.0001
504 EXTRA DOSE ADMINISTERED 6 0.0001
505 TASTE DISORDER 3 0.0001
506 PRODUCT TASTE ABNORMAL 2 0.0001
507 TACHYPNOEA 2 0.0001
508 PALLOR 4 0.0001
509 HYPOAESTHESIA 22 0.0001
510 MOOD ALTERED 4 0.0001
511 AKATHISIA 2 0.0001
512 GINGIVAL BLEEDING 2 0.0001
513 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
514 ECCHYMOSIS 1 0.0001
515 UNEVALUABLE EVENT 11 0.0001
516 INJECTION SITE ERYTHEMA 18 0.0001
517 HAIR GROWTH ABNORMAL 1 0.0001
518 LARGE INTESTINE POLYP 1 0.0001
519 ORAL DISCOMFORT 2 0.0001
520 AUTOIMMUNE HEPATITIS 1 0.0001
521 FORMICATION 1 0.0001
522 FEELING COLD 4 0.0001
523 COORDINATION ABNORMAL 2 0.0001
524 RASH MACULAR 5 0.0001
525 WEIGHT INCREASED 32 0.0001
526 BLINDNESS UNILATERAL 2 0.0001
527 SLEEP DISORDER 10 0.0001
528 SEASONAL ALLERGY 2 0.0001
529 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
530 HAND FRACTURE 1 0.0001
531 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
532 JOINT INJURY 3 0.0001
533 IRRITABLE BOWEL SYNDROME 3 0.0001
534 CONVULSION 8 0.0001
535 PARAESTHESIA 22 0.0001
536 HYPERHIDROSIS 18 0.0001
537 PRURITUS GENERALISED 3 0.0001
538 PANIC REACTION 1 0.0001
539 HYPERTHYROIDISM 2 0.0001
540 CRYING 5 0.0001
541 ABDOMINAL PAIN 32 0.0001
542 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
543 NAUSEA 108 0.0001
544 ACUTE MYOCARDIAL INFARCTION 4 0.0001
545 BLINDNESS TRANSIENT 1 0.0001
546 FEELING DRUNK 1 0.0001
547 COLITIS ULCERATIVE 6 0.0001
548 HYDRONEPHROSIS 1 0.0001
549 DYSPNOEA EXERTIONAL 5 0.0001
550 PAROSMIA 1 0.0001
551 LACRIMATION INCREASED 4 0.0001
552 ECONOMIC PROBLEM 2 0.0001
553 ACIDOSIS 1 0.0001
554 HEADACHE 82 0.0001
555 MUSCLE SPASMS 24 0.0001
556 LIPASE INCREASED 1 0.0001
557 MUSCLE TWITCHING 3 0.0001
558 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
559 DISTURBANCE IN ATTENTION 7 0.0001
560 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
561 DRUG-INDUCED LIVER INJURY 4 0.0001
562 DEPRESSION 29 0.0001
563 AFFECTIVE DISORDER 1 0.0001
564 CYANOSIS 2 0.0001
565 SINUSITIS 13 0.0001
566 DYSPHAGIA 12 0.0001
567 FURUNCLE 1 0.0001
568 PNEUMOTHORAX 2 0.0001
569 PRODUCT PRESCRIBING ERROR 3 0.0001
570 RESPIRATORY TRACT CONGESTION 2 0.0001
571 HALLUCINATION, AUDITORY 2 0.0001
572 GINGIVAL PAIN 1 0.0001
573 OBESITY 2 0.0001
574 MULTIPLE SCLEROSIS 6 0.0001
575 SCIATICA 2 0.0001
576 URTICARIA 21 0.0001
577 FEELING ABNORMAL 30 0.0001
578 DIABETIC KETOACIDOSIS 3 0.0001
579 SENSORY DISTURBANCE 2 0.0001
580 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
581 SWELLING FACE 8 0.0001
582 INJECTION SITE URTICARIA 3 0.0001
583 METASTASES TO BONE 2 0.0001
584 LETHARGY 7 0.0001
585 MANIA 2 0.0001
586 INFLUENZA LIKE ILLNESS 10 0.0001
587 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
588 MUSCLE INJURY 1 0.0001
589 AGEUSIA 3 0.0001
590 HAEMODIALYSIS 1 0.0001
591 CANDIDA INFECTION 2 0.0001
592 HEMIPARESIS 2 0.0001
593 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
594 INSOMNIA 31 0.0001
595 RASH GENERALISED 3 0.0001
596 MYOPATHY 1 0.0001
597 CARDIAC MURMUR 1 0.0001
598 HYSTERECTOMY 1 0.0001
599 DEVICE DEFECTIVE 2 0.0001
600 DEVICE DISLOCATION 5 0.0001
601 ORTHOSTATIC HYPOTENSION 2 0.0001
602 DISCOMFORT 7 0.0001
603 DEAFNESS 3 0.0001
604 SPEECH DISORDER 6 0.0001
605 DERMATITIS ATOPIC 6 0.0001
606 DEPRESSED MOOD 6 0.0001
607 IMMUNOSUPPRESSION 1 0.0001
608 ISCHAEMIC STROKE 2 0.0001
609 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
610 JAUNDICE 3 0.0001
611 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
612 PALPITATIONS 13 0.0001
613 OROPHARYNGEAL DISCOMFORT 1 0.0001
614 TOOTHACHE 2 0.0001
615 LUPUS-LIKE SYNDROME 1 0.0001
616 NEPHROLITHIASIS 5 0.0001
617 TREMOR 18 0.0001
618 NERVE COMPRESSION 1 0.0001
619 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
620 OROPHARYNGEAL PAIN 10 0.0001
621 DYSGEUSIA 8 0.0001
622 HAEMOPTYSIS 3 0.0001
623 EYE PAIN 6 0.0001
624 PHOTOPHOBIA 2 0.0001
625 LACERATION 1 0.0001
626 FOOT FRACTURE 2 0.0001
627 DEHYDRATION 14 0.0001
628 FEELING JITTERY 2 0.0001
629 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
630 GLAUCOMA 2 0.0001
631 HYPERCHOLESTEROLAEMIA 1 0.0001
632 DIZZINESS POSTURAL 1 0.0001
633 DYSSTASIA 3 0.0001
634 HAEMORRHOIDS 2 0.0001
635 HYPERSENSITIVITY 19 0.0001
636 VOMITING 48 0.0001
637 KNEE OPERATION 1 0.0001
638 PSYCHOTIC DISORDER 3 0.0001
639 EMBEDDED DEVICE 1 0.0001
640 SYNCOPE 10 0.0001
641 INJECTION SITE RASH 3 0.0001
642 NEUTROPHIL COUNT INCREASED 1 0.0001
643 NASOPHARYNGITIS 18 0.0001
644 EUPHORIC MOOD 1 0.0001
645 LIMB DISCOMFORT 3 0.0001
646 INFLAMMATION 5 0.0001
647 RASH 42 0.0001
648 EYE DISCHARGE 1 0.0001
649 NERVOUS SYSTEM DISORDER 3 0.0001
650 PETECHIAE 1 0.0001
651 INTENTIONAL DRUG MISUSE 2 0.0001
652 DERMATITIS 2 0.0001
653 FOLLICULITIS 1 0.0001
654 JOINT DISLOCATION 1 0.0001
655 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
656 HYPOTHYROIDISM 3 0.0001
657 POOR QUALITY SLEEP 2 0.0001
658 HOT FLUSH 7 0.0001
659 RASH PRURITIC 5 0.0001
660 FAECES DISCOLOURED 2 0.0001
661 TREATMENT NONCOMPLIANCE 5 0.0001
662 INTENTIONAL PRODUCT MISUSE 8 0.0001
663 INJECTION SITE SWELLING 7 0.0001
664 EMOTIONAL DISTRESS 11 0.0001
665 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
666 DIZZINESS 45 0.0001
667 VIRAL INFECTION 3 0.0001
668 ARTHROPATHY 5 0.0001
669 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
670 HEPATOTOXICITY 2 0.0001
671 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
672 ABDOMINAL DISCOMFORT 15 0.0001
673 EYE PRURITUS 3 0.0001
674 THROAT IRRITATION 4 0.0001
675 ADVERSE DRUG REACTION 8 0.0001
676 PANCREATITIS ACUTE 2 0.0001
677 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
678 VISUAL IMPAIRMENT 11 0.0001
679 EYE INFECTION 1 0.0001
680 HEART RATE IRREGULAR 2 0.0001
681 ASTHMA 10 0.0001
682 PRODUCT QUALITY ISSUE 12 0.0001
683 FLATULENCE 5 0.0001
684 CHEST DISCOMFORT 9 0.0001
685 MICTURITION URGENCY 1 0.0001
686 GASTRIC DISORDER 3 0.0001
687 SUICIDAL IDEATION 8 0.0001
688 SHOCK 2 0.0001
689 EYE IRRITATION 5 0.0001
690 DRY MOUTH 7 0.0001
691 HAEMORRHAGE 9 0.0001
692 SURGERY 5 0.0001
693 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
694 MUSCLE RIGIDITY 1 0.0001
695 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
696 HYPOGLYCAEMIA 4 0.0001
697 BURSITIS 1 0.0001
698 PRESYNCOPE 2 0.0001
699 NEURALGIA 2 0.0001
700 NO THERAPEUTIC RESPONSE 1 0.0001
701 DYSPEPSIA 8 0.0001
702 CARDIOMEGALY 1 0.0001
703 INJECTION SITE EXTRAVASATION 1 0.0001
704 ILEUS 1 0.0001
705 ASTHENIA 30 0.0001
706 PAIN 49 0.0001
707 SOMNOLENCE 16 0.0001
708 DIABETES MELLITUS 6 0.0001
709 FLUID RETENTION 4 0.0001
710 FATIGUE 61 0.0001
711 GASTROINTESTINAL DISORDER 7 0.0001
712 PAIN IN EXTREMITY 23 0.0001
713 GENITAL HAEMORRHAGE 1 0.0001
714 ANOREXIA 1 0.0001
715 UNRESPONSIVE TO STIMULI 2 0.0001
716 NO ADVERSE EVENT 14 0.0001
717 HIATUS HERNIA 1 0.0001
718 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
719 NODULE 1 0.0001
720 PSORIASIS 10 0.0001
721 ECZEMA 4 0.0001
722 APPLICATION SITE ERYTHEMA 2 0.0001
723 JOINT STIFFNESS 2 0.0001
724 ABNORMAL BEHAVIOUR 3 0.0001
725 EAR INFECTION 2 0.0001
726 HAIR TEXTURE ABNORMAL 1 0.0001
727 MALIGNANT MELANOMA 1 0.0001
728 PRODUCT USE ISSUE 14 0.0001
729 FEAR 2 0.0001
730 PAIN OF SKIN 2 0.0001
731 FREQUENT BOWEL MOVEMENTS 2 0.0001
732 PSORIATIC ARTHROPATHY 3 0.0001
733 DYSKINESIA 3 0.0001
734 CONSTIPATION 16 0.0001
735 IMPAIRED GASTRIC EMPTYING 1 0.0001
736 OSTEOPOROSIS 3 0.0001
737 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
738 PRURITUS 28 0.0001
739 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
740 APPLICATION SITE RASH 1 0.0001
741 INJECTION SITE REACTION 5 0.0001
742 DRUG DOSE OMISSION 12 0.0001
743 ABNORMAL DREAMS 2 0.0001
744 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
745 ROAD TRAFFIC ACCIDENT 3 0.0001
746 HEPATOCELLULAR INJURY 1 0.0001
747 CHEST PAIN 13 0.0001
748 RED BLOOD CELL COUNT DECREASED 2 0.0001
749 ACCIDENTAL UNDERDOSE 1 0.0001
750 CONDITION AGGRAVATED 21 0.0001
751 LIVER FUNCTION TEST ABNORMAL 2 0.0001
752 APATHY 1 0.0001
753 PRODUCT STORAGE ERROR 6 0.0001
754 GASTROENTERITIS 1 0.0001
755 CHILLS 8 0.0001
756 NASAL CONGESTION 4 0.0001
757 ILLNESS 7 0.0001
758 ANGIOEDEMA 3 0.0001
759 CARDIOMYOPATHY 1 0.0001
760 BRONCHITIS 5 0.0001
761 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
762 DEVICE ISSUE 6 0.0001
763 DIARRHOEA 43 0.0001
764 PREMATURE BABY 2 0.0001
765 HYPOAESTHESIA ORAL 1 0.0001
766 APHASIA 2 0.0001
767 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
768 THERAPEUTIC RESPONSE DECREASED 4 0.0001
769 DEVICE FAILURE 1 0.0001
770 MEMORY IMPAIRMENT 9 0.0001
771 INJECTION SITE PAIN 20 0.0001
772 HOSPITALISATION 10 0.0001
773 PHARYNGEAL OEDEMA 1 0.0001
774 HYPOKALAEMIA 3 0.0001
775 MYALGIA 11 0.0001
776 PRODUCT DOSE OMISSION ISSUE 19 0.0001
777 MUSCULOSKELETAL CHEST PAIN 1 0.0001
778 BACK PAIN 15 0.0001
779 URINARY TRACT INFECTION 11 0.0001
780 RENAL DISORDER 3 0.0001
781 LUNG INFECTION 1 0.0001
782 BLOOD CHOLESTEROL INCREASED 3 0.0001
783 MALAISE 28 0.0001
784 BRAIN FOG 1 0.0001
785 ARRHYTHMIA 3 0.0001
786 OCULAR HYPERAEMIA 3 0.0001
787 HEAD INJURY 2 0.0001
788 ABDOMINAL PAIN UPPER 13 0.0001
789 RASH ERYTHEMATOUS 3 0.0001
790 GAIT DISTURBANCE 12 0.0001
791 ABSCESS 1 0.0001
792 INJECTION SITE HAEMORRHAGE 5 0.0001
793 METABOLIC ACIDOSIS 2 0.0001
794 MOVEMENT DISORDER 2 0.0001
795 MUSCLE TIGHTNESS 1 0.0001
796 DEVICE EXPULSION 4 0.0001
797 AMNESIA 4 0.0001
798 EYE DISORDER 2 0.0001
799 STAPHYLOCOCCAL INFECTION 2 0.0001
800 DRUG LEVEL INCREASED 1 0.0001
801 DECREASED APPETITE 14 0.0001
802 DRY EYE 3 0.0001
803 FUNGAL INFECTION 2 0.0001
804 GAIT INABILITY 2 0.0001
805 BLOOD UREA INCREASED 1 0.0001
806 CIRCULATORY COLLAPSE 1 0.0001
807 HEPATIC ENZYME INCREASED 4 0.0001
808 JOINT SWELLING 7 0.0001
809 NIGHTMARE 2 0.0001
810 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
811 COUGH 16 0.0001
812 BURNING SENSATION 4 0.0001
813 DEVICE MALFUNCTION 4 0.0001
814 LYMPHADENOPATHY 2 0.0001
815 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
816 HEAD DISCOMFORT 1 0.0001
817 TACHYCARDIA 5 0.0001
818 ALOPECIA 11 0.0001
819 THERAPY INTERRUPTED 4 0.0001
820 DRUG EFFECT DECREASED 3 0.0001
821 COMPLICATION OF DEVICE REMOVAL 1 0.0001
822 C-REACTIVE PROTEIN INCREASED 2 0.0001
823 BONE DISORDER 1 0.0001
824 END STAGE RENAL DISEASE 1 0.0001
825 RESTLESSNESS 2 0.0001
826 DYSURIA 2 0.0001
827 ANAPHYLACTIC REACTION 3 0.0001
828 INJECTION SITE MASS 2 0.0001
829 FALL 18 0.0001
830 MEDICATION ERROR 3 0.0001
831 CONJUNCTIVITIS 1 0.0001
832 EYE SWELLING 2 0.0001
833 SWELLING 5 0.0001
834 BLISTER 3 0.0001
835 OXYGEN SATURATION DECREASED 3 0.0001
836 HEPATIC CIRRHOSIS 1 0.0001
837 INTESTINAL OBSTRUCTION 2 0.0001
838 RHEUMATOID ARTHRITIS 6 0.0001
839 COLITIS 2 0.0001
840 GASTRIC ULCER 1 0.0001
841 MUSCULOSKELETAL DISORDER 1 0.0001
842 HERPES ZOSTER 3 0.0001
843 CHOLESTASIS 1 0.0001
844 DRUG PRESCRIBING ERROR 1 0.0001
845 LOWER LIMB FRACTURE 1 0.0001
846 HERNIA 1 0.0001
847 CHOKING 1 0.0001
848 WHEEZING 3 0.0001
849 DISABILITY 1 0.0001
850 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
851 ARTHRALGIA 21 0.0001
852 DISORIENTATION 2 0.0001
853 HEART RATE INCREASED 5 0.0001
854 HAEMATOCRIT DECREASED 1 0.0001
855 DRUG INTERACTION 8 0.0001
856 CONFUSIONAL STATE 8 0.0000
857 SUICIDE ATTEMPT 3 0.0000
858 STOMATITIS 3 0.0000
859 OEDEMA PERIPHERAL 6 0.0000
860 VERTIGO 3 0.0000
861 BLINDNESS 2 0.0000
862 HAEMOGLOBIN DECREASED 5 0.0000
863 ERYTHEMA 10 0.0000
864 INJECTION SITE WARMTH 1 0.0000
865 PERITONITIS 1 0.0000
866 KNEE ARTHROPLASTY 1 0.0000
867 OSTEOARTHRITIS 2 0.0000
868 LOSS OF CONSCIOUSNESS 6 0.0000
869 HYPOACUSIS 2 0.0000
870 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
871 MENTAL DISORDER 2 0.0000
872 DRUG INEFFECTIVE 60 0.0000
873 APPLICATION SITE PAIN 1 0.0000
874 INFUSION RELATED REACTION 3 0.0000
875 DRY SKIN 6 0.0000
876 GLOSSODYNIA 1 0.0000
877 THERAPY NON-RESPONDER 2 0.0000
878 CHROMATURIA 1 0.0000
879 APPLICATION SITE PRURITUS 1 0.0000
880 MUSCULAR WEAKNESS 5 0.0000
881 INCORRECT DOSE ADMINISTERED 10 0.0000
882 SKIN IRRITATION 2 0.0000
883 ADVERSE EVENT 4 0.0000
884 PERICARDIAL EFFUSION 1 0.0000
885 WEIGHT DECREASED 12 0.0000
886 BREAST CANCER 4 0.0000
887 COGNITIVE DISORDER 2 0.0000
888 HYPERTENSION 9 0.0000
889 PRODUCTIVE COUGH 2 0.0000
890 SKIN BURNING SENSATION 3 0.0000
891 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
892 LOCALISED INFECTION 1 0.0000
893 AGITATION 3 0.0000
894 DYSPNOEA 23 0.0000
895 ABASIA 1 0.0000
896 AGGRESSION 2 0.0000
897 HALLUCINATION 3 0.0000
898 HYPOPHAGIA 1 0.0000
899 HEPATITIS 1 0.0000
900 ANAPHYLACTIC SHOCK 1 0.0000
901 GASTRITIS 1 0.0000
902 PANCREATITIS 2 0.0000
903 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
904 OEDEMA 2 0.0000
905 HAEMATOCHEZIA 2 0.0000
906 MENTAL STATUS CHANGES 1 0.0000
907 INFLUENZA 4 0.0000
908 NECK PAIN 2 0.0000
909 SKIN EXFOLIATION 3 0.0000
910 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
911 HYPONATRAEMIA 2 0.0000
912 CEREBROVASCULAR ACCIDENT 6 0.0000
913 HYPERSOMNIA 1 0.0000
914 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
915 NEEDLE ISSUE 1 0.0000
916 MUSCULOSKELETAL STIFFNESS 3 0.0000
917 DYSPHONIA 2 0.0000
918 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
919 LABORATORY TEST ABNORMAL 1 0.0000
920 BLOOD POTASSIUM DECREASED 1 0.0000
921 HEPATIC FAILURE 1 0.0000
922 CORONARY ARTERY DISEASE 1 0.0000
923 PLEURAL EFFUSION 2 0.0000
924 BLOOD PRESSURE INCREASED 5 0.0000
925 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
926 PERIPHERAL SWELLING 5 0.0000
927 PYREXIA 11 0.0000
928 NEUROPATHY PERIPHERAL 3 0.0000
929 CYSTITIS 1 0.0000
930 CONTUSION 3 0.0000
931 HIP FRACTURE 1 0.0000
932 DRUG INTOLERANCE 3 0.0000
933 OSTEONECROSIS 1 0.0000
934 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
935 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
936 ANGER 1 0.0000
937 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
938 HAEMATURIA 1 0.0000
939 HYPERKALAEMIA 1 0.0000
940 HEART RATE DECREASED 1 0.0000
941 MOBILITY DECREASED 2 0.0000
942 DRUG EFFECT INCOMPLETE 1 0.0000
943 HYPERGLYCAEMIA 1 0.0000
944 UNDERDOSE 2 0.0000
945 ACCIDENTAL OVERDOSE 1 0.0000
946 THROMBOCYTOPENIA 3 0.0000
947 CHRONIC KIDNEY DISEASE 2 0.0000
948 ACUTE KIDNEY INJURY 4 0.0000
949 SEIZURE 3 0.0000
950 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
951 ARTHRITIS 2 0.0000
952 OFF LABEL USE 22 0.0000
953 DEVICE BREAKAGE 1 0.0000
954 NEUTROPHIL COUNT DECREASED 1 0.0000
955 LUNG NEOPLASM MALIGNANT 1 0.0000
956 DEVICE LEAKAGE 1 0.0000
957 DRUG WITHDRAWAL SYNDROME 2 0.0000
958 RENAL FAILURE 3 0.0000
959 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
960 VISION BLURRED 3 0.0000
961 CARDIAC DISORDER 2 0.0000
962 BLOOD GLUCOSE INCREASED 4 0.0000
963 DISEASE RECURRENCE 1 0.0000
964 COMA 1 0.0000
965 ANAEMIA 4 0.0000
966 BLOOD GLUCOSE DECREASED 1 0.0000
967 LUNG DISORDER 1 0.0000
968 HYPOTENSION 4 0.0000
969 MUSCULOSKELETAL PAIN 1 0.0000
970 BRADYCARDIA 1 0.0000
971 PLATELET COUNT DECREASED 2 0.0000
972 OVERDOSE 4 0.0000
973 PNEUMONIA 6 0.0000
974 MYOCARDIAL INFARCTION 3 0.0000
975 COVID-19 3 0.0000
976 BONE PAIN 1 0.0000
977 ILL-DEFINED DISORDER 1 0.0000
978 BLOOD CREATININE INCREASED 1 0.0000
979 EPISTAXIS 1 0.0000
980 DRUG DOSE OMISSION BY DEVICE 1 0.0000
981 CARDIAC FAILURE 1 0.0000
982 CARDIAC FAILURE CONGESTIVE 1 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
984 CARDIAC ARREST 1 0.0000
985 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
986 DEATH 10 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
988 DISEASE PROGRESSION 1 0.0000
989 INFECTION 1 0.0000